Difference between revisions of "Template:Did you know nominations/Azeloprazole"
Jump to navigation
Jump to search
imported>Gerda Arendt (ty) |
imported>Yoninah (to Prep 2) |
||
| Line 1: | Line 1: | ||
| − | + | <noinclude>[[Category:Passed DYK nominations from December 2017]]<div style="background-color: #F3F9FF; margin: 2em 0 0 0; padding: 0 10px 0 10px; border: 1px solid #AAAAAA;"> | |
| − | + | :''The following is an archived discussion of the DYK nomination of the article below. <span style="color:red">'''Please do not modify this page.'''</span> Subsequent comments should be made on the appropriate discussion page (such as [[{{TALKPAGENAME}}|this nomination's talk page]], [[Talk:{{SUBPAGENAME}}|the article's talk page]] or [[Wikipedia talk:Did you know]]), unless there is consensus to re-open the discussion at this page. '''No further edits should be made to this page'''.'' | |
| − | + | ||
| − | | | + | The result was: '''promoted''' by [[User:Yoninah|Yoninah]] ([[User talk:Yoninah|talk]]) 22:45, 15 January 2018 (UTC)<br /> |
{{DYK conditions}} | {{DYK conditions}} | ||
====Azeloprazole==== | ====Azeloprazole==== | ||
| Line 8: | Line 8: | ||
<div style="float:right; margin-left:0.5em;" id="mp-dyk-img"> | <div style="float:right; margin-left:0.5em;" id="mp-dyk-img"> | ||
{{main page image|image=Azeloprazolespin.gif|caption=Azeloprazole spinning along an axis.|width=120x133}} | {{main page image|image=Azeloprazolespin.gif|caption=Azeloprazole spinning along an axis.|width=120x133}} | ||
| − | </div | + | </div> |
| − | |||
| − | |||
| − | |||
| − | |||
* ... that '''[[azeloprazole]]''' was designed with [[pharmacogenomics]] in mind? <small>Source: "Azeloprazole sodium was synthesized to overcome issues associated with the metabolism of marketed PPIs by CYP2C19." (Toda R. et al. ''The Journal of Clinical Pharmacology''. 2017;00(0):1–9. DOI:10.1002/jcph.1038.)</small> | * ... that '''[[azeloprazole]]''' was designed with [[pharmacogenomics]] in mind? <small>Source: "Azeloprazole sodium was synthesized to overcome issues associated with the metabolism of marketed PPIs by CYP2C19." (Toda R. et al. ''The Journal of Clinical Pharmacology''. 2017;00(0):1–9. DOI:10.1002/jcph.1038.)</small> | ||
:* | :* | ||
:* ''Comment'': Moved from sandbox. About 1900 characters. Using DYK credit from [[Template:Did you know nominations/Dominique Blake|Dominique Blake]]. | :* ''Comment'': Moved from sandbox. About 1900 characters. Using DYK credit from [[Template:Did you know nominations/Dominique Blake|Dominique Blake]]. | ||
<small>Created by [[User:Biochemistry&Love|Biochemistry&Love]] ([[User talk:Biochemistry&Love|talk]]). Self-nominated at 06:02, 26 December 2017 (UTC).</small> | <small>Created by [[User:Biochemistry&Love|Biochemistry&Love]] ([[User talk:Biochemistry&Love|talk]]). Self-nominated at 06:02, 26 December 2017 (UTC).</small> | ||
| − | |||
| − | |||
| − | |||
: [[File:Symbol voting keep.svg|16px]] Interesting, on good scientific sources, those I can't access accepted AGF, no copyvio obvious. For my taste, the short article has too many headers, please try to condense. It also wouldn't hurt to explain a few things in the language of the average reader, even if there's a link. The image is licenses and attractive, but the caption is very long. (I added a letter.) --[[User:Gerda Arendt|Gerda Arendt]] ([[User talk:Gerda Arendt|talk]]) 14:55, 26 December 2017 (UTC) | : [[File:Symbol voting keep.svg|16px]] Interesting, on good scientific sources, those I can't access accepted AGF, no copyvio obvious. For my taste, the short article has too many headers, please try to condense. It also wouldn't hurt to explain a few things in the language of the average reader, even if there's a link. The image is licenses and attractive, but the caption is very long. (I added a letter.) --[[User:Gerda Arendt|Gerda Arendt]] ([[User talk:Gerda Arendt|talk]]) 14:55, 26 December 2017 (UTC) | ||
| Line 28: | Line 21: | ||
::::{{reply|User:Gerda Arendt}} Completed! Let me know if that will suffice. (: ―[[User:Biochemistry&Love|<span style="letter-spacing:1px"><span style="color:Teal">'''Bio'''</span><span style="color:seagreen">chemistry</span><span style="color:Teal">🙴</span><span style="color:firebrick">❤</span></span>]] 03:51, 2 January 2018 (UTC) | ::::{{reply|User:Gerda Arendt}} Completed! Let me know if that will suffice. (: ―[[User:Biochemistry&Love|<span style="letter-spacing:1px"><span style="color:Teal">'''Bio'''</span><span style="color:seagreen">chemistry</span><span style="color:Teal">🙴</span><span style="color:firebrick">❤</span></span>]] 03:51, 2 January 2018 (UTC) | ||
::::: Thank you! [[User:Gerda Arendt/Christmas 2017|Happy 2018!]]! --[[User:Gerda Arendt|Gerda Arendt]] ([[User talk:Gerda Arendt|talk]]) 08:26, 2 January 2018 (UTC) | ::::: Thank you! [[User:Gerda Arendt/Christmas 2017|Happy 2018!]]! --[[User:Gerda Arendt|Gerda Arendt]] ([[User talk:Gerda Arendt|talk]]) 08:26, 2 January 2018 (UTC) | ||
| − | {{-}} | + | {{-}}</div></noinclude><!--Please do not write below this line or remove this line. Place comments above this line.--> |
Latest revision as of 22:45, 15 January 2018
- The following is an archived discussion of the DYK nomination of the article below. Please do not modify this page. Subsequent comments should be made on the appropriate discussion page (such as this nomination's talk page, the article's talk page or Wikipedia talk:Did you know), unless there is consensus to re-open the discussion at this page. No further edits should be made to this page.
The result was: promoted by Yoninah (talk) 22:45, 15 January 2018 (UTC)
| DYK toolbox |
|---|
Azeloprazole
- ... that azeloprazole was designed with pharmacogenomics in mind? Source: "Azeloprazole sodium was synthesized to overcome issues associated with the metabolism of marketed PPIs by CYP2C19." (Toda R. et al. The Journal of Clinical Pharmacology. 2017;00(0):1–9. DOI:10.1002/jcph.1038.)
- Comment: Moved from sandbox. About 1900 characters. Using DYK credit from Dominique Blake.
Created by Biochemistry&Love (talk). Self-nominated at 06:02, 26 December 2017 (UTC).
Interesting, on good scientific sources, those I can't access accepted AGF, no copyvio obvious. For my taste, the short article has too many headers, please try to condense. It also wouldn't hurt to explain a few things in the language of the average reader, even if there's a link. The image is licenses and attractive, but the caption is very long. (I added a letter.) --Gerda Arendt (talk) 14:55, 26 December 2017 (UTC)
- Template:Reply Thank you for your review! I tried to keep the headers per WP:PHARMMOS, but I understand that it does seem silly to have something like "Pharmacology" only include the "Mechanism of action." Do you still recommend condensing them? What sections do you think could benefit from additional clarity for the lay reader? The caption does seem a bit long; what do you think of it now? ―Biochemistry🙴❤ 03:29, 27 December 2017 (UTC)
- I don't know how "stiff" the standard headers are. In music, I usually have "Text" and "Melody", but if one of them has little content I do "Text and melody". - I don't know proton pump inhibitor. First step to more readability would be to repeat the link in the body, second, a few words in the body about what that means, - if you don't want to loose readers at that point. Think about them ;)
--Gerda Arendt (talk) 10:08, 27 December 2017 (UTC)
- Template:Reply Completed! Let me know if that will suffice. (: ―Biochemistry🙴❤ 03:51, 2 January 2018 (UTC)
- Thank you! Happy 2018!! --Gerda Arendt (talk) 08:26, 2 January 2018 (UTC)
- Template:Reply Completed! Let me know if that will suffice. (: ―Biochemistry🙴❤ 03:51, 2 January 2018 (UTC)
